Back To Results

Treatment *CME

November 06, 2019

Biosimilars for Psoriasis (CME)

Episode 44

Learn about biosimilars, their efficacy compared with biologics, and their current and upcoming status as a psoriasis treatment from Dr. Grace Kimmel, who completed a fellowship in dermatopharmacology and is now with the Department of Dermatology at Icahn School of Medicine at Mount Sinai in New York.

To view disclosure information and claim credit, visit this page.

For additional CME, access the article mentioned in this podcast https://cme.psoriasis.org/content/efficacy-biosimilars-psoriasis

This podcast is supported by unrestricted educational grants from Bristol-Myers Squibb, Lilly and Ortho Dermatologics.

Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2020 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.